Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Harmony Biosciences (HRMY) : Charting a Course for Sustained Growth
Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in…
Anebulo Pharmaceuticals Secures NIH Grant for Emergency Cannabis Antidote Development
Applied Therapeutics Surges on Positive FDA Update for Govorestat
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms
Finance
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Mustang Bio Inc
Tag: Mustang Bio Inc
Mustang Bio Inc. (NASDAQ:MBIO) Signs Technology Transfer and GMP Manufacturing Deal...
Gavins Felicity
-
December 11, 2020
0
Mustang Bio Inc. (NASDAQ:MBIO) Commences Dosing Of Patients With MB-102 And...
Gavins Felicity
-
October 20, 2020
0
Mustang Bio Inc. (NASDAQ:MBIO) Enters Agreement With SIRION For LentiBOOST™ Tech...
Ward Sport
-
October 19, 2020
0
Mustang Bio Inc. (NASDAQ:MBIO) Receives Orphan Drug Designation For Its MB-207...
Gavins Felicity
-
October 5, 2020
0
Mustang Bio Inc. (NASDAQ:MBIO) Receives Orphan Drug Designation For MB-207 in...
Kate Hudson
-
October 1, 2020
0
1
2
Page 1 of 2
Recent Post
Harmony Biosciences (HRMY) : Charting a Course for Sustained Growth
Matt Wade
-
September 20, 2024
0
Harmony Biosciences (NASDAQ: HRMY) recently released its Q2 2024 earnings, demonstrating robust growth and strategic progress. The company reported a 29% year-over-year...
Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in...
September 20, 2024
Anebulo Pharmaceuticals Secures NIH Grant for Emergency Cannabis Antidote Development
September 20, 2024
Applied Therapeutics Surges on Positive FDA Update for Govorestat
September 18, 2024
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms
September 18, 2024